Last Updated : July 9, 2008
Details
FilesGeneric Name:
Ambrisentan
Project Status:
Complete
Therapeutic Area:
Pulmonary arterial hypertension (WHO class II and III)
Manufacturer:
GlaxoSmithKline Inc.
Brand Name:
Volibris
Project Line:
Reimbursement Review
Project Number:
SR0142-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Pulmonary arterial hypertension (WHO class II and III)
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation:
Files
Last Updated : July 9, 2008